| Accession Number | 0001797672-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | — | Mar 5, 2026 | Sale | 1,366 | $12.90 | $17,625.50 | 69,956 | Direct | — | View Details |